Nouvelles

CAPDM Welcomes Paladin Labs Inc.

jeudi, 20 janvier 2022

CAPDM Welcomes New Member Paladin Labs Inc. With headquarters in Montréal, Canada, Paladin Labs Inc. is a leading specialty pharmaceutical company focused on acquiring or licensing emerging pharmaceuticals for the Canadian market.
 
Their dedicated sales and marketing organization has propelled Paladin to become one of Canada’s pioneers in specialty pharmaceuticals.
 

JAMP and Alvotech Announce Canadian Approval of SIMLANDI™

jeudi, 20 janvier 2022

January 20, 2022
JAMP and Alvotech Announce Canadian Approval of SIMLANDI™, a High-Concentration Biosimilar to Humira®, Providing Access  to Previously Unavailable Versions in Canada 

Read the Full Release

CAPDM Welcomes Aspen Canada Inc.

jeudi, 20 janvier 2022

CAPDM Welcomes New Member Aspen Canada Inc. Headquartered in Durban, South Africa, with offices in Oakville , Ontario , Aspen is a global specialty and branded pharmaceutical company, improving the health of patients across the world through our high quality and affordable medicines. 

CAPDM Welcomes Fresenius Kabi Canada

jeudi, 20 janvier 2022

CAPDM Welcomes New Member Fresenius Kabi Canada, specializes in lifesaving medicines and technologies for infusion, transfusion and parenteral nutrition. 
  

CAPDM Welcomes Organon

mardi, 14 décembre 2021

CAPDM Welcomes New Member Organon. Organon is the largest pharma company of its size dedicated to women’s health. 

CAPDM Welcomes Sentrex Health Solutions

mercredi, 8 décembre 2021

CAPDM welcomes new member Sentrex Health Solutions. Utilizing strategic distribution models and patient support programs backed by powerful, integrated technology and experienced cross-functional teams, Sentrex provides innovative solutions focused on ensuring patients have the access and support they need to optimize their treatment outcomes.


  

Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide

mercredi, 1 septembre 2021

September 1, 2021
Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market.

Read the Full Release

ConnectRx Pharmaceutical Distribution & Wholesale Announcement

mardi, 17 août 2021

In an effort to continuously meet and support your product and distribution needs, we are thrilled to announce that ConnectRx Pharmaceutical Distribution & Wholesale will be moving to a new state of the art 6,000 sq. ft facility in early Q4 of 2021. 

Andlauer Healthcare Group Appoints Dean Berg as President, Logistics

mardi, 8 juin 2021

Andlauer Healthcare Group Inc. announced today the appointment of Dean Berg as the Company's new President, Logistics. The appointment is effective immediately.
Read the Full Release 

Teva Canada Provides New Patient Resource to Empower Those Living with Chronic Conditions

mardi, 8 juin 2021

Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd, is pleased to announce the launch of Life Effects, a peer-to-peer support platform for patients living with one or more chronic conditions and those who care for them.
Read the Full Release